腾盛博药-B · Brii Biosciences Limited
Last · HKSEHK$0.85+0.005 (+0.59%)close · yahoo · 10h ago
Market capHK$613.9M722.2M sh
P/E · TTM-3.0fwd -1.7 · eps -0.28 · loss
Beta1.25vs S&P 500
Div yield0.00%annual · TTM
52w range
HK$0.815HK$1.99
Volume567.5Ksession
| Revenue | ¥18.6M |
|---|---|
| Operating income | ¥-222.2M |
| Net income | ¥-224.1M |
| Operating margin | -1194.1% |
| Net margin | -1204.3% |
| Return on equity | -9.6% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-04-23
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Runway Low
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -22526.7%
- Cash Runway Low — Cash runway ~1.8 years
- Rd Intensity High — R&D/Revenue 2658.5%
Documents
FormReporting forFiledFlags